Zimmer Biomet (NYSE:ZBH) Price Target Cut to $130.00
Zimmer Biomet (NYSE:ZBH – Free Report) had its target price decreased by Royal Bank of Canada from $140.00 to $130.00 in a research note released on Thursday, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the medical equipment provider’s stock. Other research analysts also recently issued reports about the company. Argus […]
More Stories
Where Food Comes From Reports Financial Results for Third Quarter of 2024
Where Food Comes From, Inc. (NASDAQ:WFCF) has released its financial results for the third quarter of 2024 through a recent...
ING Groep NV Buys 240,749 Shares of The Estée Lauder Companies Inc. (NYSE:EL)
ING Groep NV increased its stake in shares of The Estée Lauder Companies Inc. (NYSE:EL – Free Report) by 393.7%...
ING Groep NV Trims Stock Holdings in Ecolab Inc. (NYSE:ECL)
ING Groep NV lessened its stake in shares of Ecolab Inc. (NYSE:ECL – Free Report) by 3.8% in the 3rd...
iShares MSCI USA Quality Factor ETF (BATS:QUAL) Shares Bought by Palo Alto Wealth Advisors LLC
Palo Alto Wealth Advisors LLC grew its holdings in iShares MSCI USA Quality Factor ETF (BATS:QUAL – Free Report) by...
ING Groep NV Grows Stake in HashiCorp, Inc. (NASDAQ:HCP)
ING Groep NV boosted its holdings in shares of HashiCorp, Inc. (NASDAQ:HCP – Free Report) by 851.2% in the 3rd...
Boston Omaha (NYSE:BOC) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPS
Boston Omaha (NYSE:BOC – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.05) earnings per...